PathAI, a company developing AI-based technology for pathologists, has raised $60 million in Series B funding. The round was led by new investor General Atlantic, with participation from General Catalyst.

General Atlantic managing director Dr. Michelle Dipp will be joining PathAI’s board of directors.

[Image courtesy: PathAI]